Senokot Tablet
Pricing Report NDC 67618-300-10

Current NADAC: $0.24706 per EA · Effective Sep 23, 2026 · Est. package price $24.71 (100 EA)

Current Package Pricing Information

The current wholesale acquisition cost for Senokot (NDC 67618-300-10) is $0.24706 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.

As a a human over the counter drug provided by Atlantis Consumer Healthcare, Inc., this medication is distributed in a 1 BOTTLE, PLASTIC in 1 CARTON / 100 TABLET in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.24706
Per EA

Effective Date
Sep 23, 2026
Billable Units
100 EA
Estimated Package Price
$24.71
Data Status
As of Oct 07, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE, PLASTIC in 1 CARTON / 100 TABLET in 1 BOTTLE, PLASTIC
Generic Benchmark
The generic equivalent rate is $0.02580 (Effective: Sep 23, 2026)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.19615 to $0.24971 per EA. Over this 12 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1962 - $0.2497
Market Volatility
27.31% Variance
Latest Trend
0.99%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $0.24706 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 23, 2026 $0.24706 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 23, 2026 $0.24706 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 19, 2026 $0.24954 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 19, 2026 $0.24954 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 19, 2026 $0.24954 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 22, 2026 $0.24956 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 22, 2026 $0.24956 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 22, 2026 $0.24956 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 17, 2026 $0.24940 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 17, 2026 $0.24940 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 17, 2026 $0.24940 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026